Premium
ESSA Pharma Inc (EPIX)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen recepto... ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Show more
March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX PR Newswire NEW YORK, Feb. 3, 2025 NEW YORK, Feb. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the...
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025 /PRNewswire/...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 PR Newswire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada...
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire SOUTH SAN...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -2.8901734104 | 1.73 | 1.79 | 1.67 | 175063 | 1.70870629 | CS |
| 4 | -0.21 | -11.1111111111 | 1.89 | 1.9 | 1.67 | 148292 | 1.73523016 | CS |
| 12 | -0.18 | -9.67741935484 | 1.86 | 1.95 | 1.57 | 334640 | 1.74821625 | CS |
| 26 | -3.04 | -64.406779661 | 4.72 | 7.88 | 1.4 | 542881 | 1.78751012 | CS |
| 52 | -7.57 | -81.8378378378 | 9.25 | 11.67 | 1.4 | 315029 | 2.622237 | CS |
| 156 | -8.4 | -83.3333333333 | 10.08 | 11.67 | 1.4 | 495323 | 4.01863242 | CS |
| 260 | -3.76 | -69.1176470588 | 5.44 | 36 | 1.4 | 387577 | 6.84623402 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
